However, we report here for the first time that CD5 levels in these subsets is different in lymphoid organs and the tumor microenvironment and that CD5-/low TILs exhibit increased markers of activation and effector function, unlike CD5low T cells in lymphoid organs. This evidence concerns the gene CD5 and neoplasm.